4-(Substituted aryl)-5-hydroxyisoquinolinone derivative
US7425563B2 · kind B2 · utility
2Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 2003 |
| Grant date | Sep 16, 2008 |
| Priority date | — |
| Expiry date | Jan 16, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides 4-substituted aryl-5-hydroxyisoquinolinone derivatives and their pharmacologically acceptable addition salts with excellent inhibitory effect on poly (ADP-ribose) synthetase.4-Substituted aryl-5-hydroxyisoquinolinone derivatives, represented by a general formula (1)and their pharmacologically acceptable addition salts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.